logo
Woman faces more than $20,000 in medical bills after wild bat flies into her mouth

Woman faces more than $20,000 in medical bills after wild bat flies into her mouth

Yahoo4 days ago
A woman from Massachusetts is facing more than $20,000 in medical bills after a wild bat flew into her mouth while she was on vacation.
In August last year, Erica Kahn, 33, was taking photos of the sky in Arizona when a bat got stuck between her head and the camera, and partially entered her mouth as she screamed, according to KFF Health News.
Her doctor father urged her to get a number of rabies vaccinations, even though Kahn doesn't believe the bat bit her. She told the outlet she had recently been forced to leave her biomedical engineering job and purchased a health insurance policy online the day after the bat flew into her mouth to help with the treatments in Arizona, Massachusetts, and Colorado.
But the insurance company rejected paying for the treatments and pointed to a 30-day waiting period.
Kahn believed she would be covered as long as she got insurance before going to the hospital in Flagstaff, Arizona, noting that she called the company before she bought the policy and that she was told services connected to an accident or 'life-threatening' emergency would be covered.
'The required waiting period for this service has not been met,' said the company. After being treated at four different treatment centers, she faced bills of $20,749.
'I thought it must have been a mistake,' she told KFF. 'I guess I was naive.'
The outlet noted that Kahn has since acquired a new job, negotiated down one of the bills, put in place a payment plan for another, and is in the appeals process for the rest.
She said she regrets allowing gaps in her healthcare coverage after she lost her job.
'That's a very big lesson I learned the hard way,' said Kahn, who still looks back at the incident with a sense of humor.
'I know what bats taste like now. It's an earthy, sweet kind of flavor,' she told KFF.
'It's actually a pretty funny story — if it weren't for the horrible medical bill that came with it.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Lysoway Therapeutics Awarded Grant from The Michael J. Fox Foundation to Advance TRPML1 Agonist to Treat Parkinson's Disease
Lysoway Therapeutics Awarded Grant from The Michael J. Fox Foundation to Advance TRPML1 Agonist to Treat Parkinson's Disease

Yahoo

time28 minutes ago

  • Yahoo

Lysoway Therapeutics Awarded Grant from The Michael J. Fox Foundation to Advance TRPML1 Agonist to Treat Parkinson's Disease

CAMBRIDGE, Mass., August 06, 2025--(BUSINESS WIRE)--Lysoway Therapeutics, Inc., a biopharmaceutical company developing small molecule modulators of lysosomal ion channels, today announced that it has received a research grant from The Michael J. Fox Foundation for Parkinson's Research (MJFF). Support comes from MJFF's Parkinson's Disease Therapeutics Pipeline Program, which focuses on candidates with strong potential to slow or halt disease progression or alleviate burdensome symptoms for those living with Parkinson's disease. Lysoway Therapeutics funding of $2.93 million will support the preclinical and translational development of Lysoway's novel, highly brain-penetrant small molecule TRPML1 agonist. The study aims to investigate whether activating TRPML1 by a novel, small molecule modulator, will enhance the lysosomal membrane calcium ion channel to restore lysosomal function and help with clearance of alpha-synuclein, the protein that is linked to the disease. "We are honored to receive this generous grant from The Michael J. Fox Foundation," said Valerie Cullen, PhD, Principal Investigator and SVP of Research and Translation at Lysoway. "TRPML1 is a high value target due to its pivotal role in sensing and responding to cellular stress. By activating this ion channel, we can engage multiple beneficial pathways that restore autophagy/lysosomal homeostasis and bolster cellular resilience. Our lead development candidate is both orally bioavailable and highly brain-penetrant, offering strong potential to modify disease progression in Parkinson's Disease." Yongchang Qiu, PhD, Founder and Chief Executive Officer of Lysoway Therapeutics, added "This funding underscores growing confidence in TRPML1 as a compelling target for Parkinson's disease. It will allow us to accelerate development of our lead TRPML1 agonist and to establish key biomarkers for target engagement, with the goal of initiating first-in-human clinical trials early next year." About Lysoway Therapeutics, in Cambridge, MA, Lysoway Therapeutics is a leader in developing therapeutically viable lysosomal ion channel modulators. The company is advancing a pipeline of small molecule activators targeting these channels to treat neurodegenerative diseases. Learn more at View source version on Contacts Media contact: Info@

Laura Loomer Is Getting a Taste of Her Own Medicine
Laura Loomer Is Getting a Taste of Her Own Medicine

Yahoo

time2 hours ago

  • Yahoo

Laura Loomer Is Getting a Taste of Her Own Medicine

Laura Loomer's conspiratorial followers are already cannibalizing her for participating in 'the swamp.' Just a day after reports emerged that Defense Secretary Pete Hegseth had tapped the far-right '9/11 truther' to help identify leakers among his staff, Loomer has now herself become the subject of intense scrutiny. Some conspiracists are accusing her of being a 'plant' for pharmaceutical companies concerned about administration policies that could cut into their bottom dollar, reported The Bulwark. The self-appointed 'loyalty enforcer' has had enormous success influencing the Trump administration from the safety of her X account: An analysis by The Daily Beast found that at least 16 individuals were fired from the federal government after Loomer singled them out as covert Democratic agents. But now her intraparty success is coming back to bite her. At issue is the recent firing of Dr. Vinay Prasad, who until last week was in charge of the Food and Drug Administration division that oversees vaccines and gene therapies. Prasad resigned from his position after Loomer accused him of being disloyal to the president, alleging he owned a Trump voodoo doll. (The claim is a mischaracterization of a rhetorical anecdote Prasad spelled out in a podcast episode.) Of note for far-right influencers: Prasad was in the midst of duking it out with Massachusetts-based drug manufacturer Sarepta over the company's drug Elevidys, which treats Duchenne muscular dystrophy. The FDA put Elevidys's clinical trials on hold last month after two patients died while taking the drug, and after another individual passed away while taking a related treatment. All three people died from acute liver toxicity. Shortly before Prasad resigned, the FDA reversed course on its decision, deciding that some patients who still had the ability to walk could receive the drug. Loomer's peers considered the connection between her attacks on Prasad, the new FDA decision, and Prasad's firing fairly obvious. Right-wing Big Pharma critic Kevin Bass accused Loomer of being a 'plant' to 'oust FDA official Vinay Prasad.' American Majority CEO Ned Ryun wrote that Loomer was 'funded by Sarepta Therapeutics to take Vinay out,' referring to the influencer as 'completely nuts.' 'The reason I find this and you so loathsome is that this behavior is the antithesis of the MAGA and MAHA movements,' Ryun added. Loomer has rejected the claims, writing to her 1.7 million followers on X that she hasn't accepted any money from Big Pharma.

4 killed in medical plane crash near Chinle Airport in northeast Arizona
4 killed in medical plane crash near Chinle Airport in northeast Arizona

Yahoo

time2 hours ago

  • Yahoo

4 killed in medical plane crash near Chinle Airport in northeast Arizona

Four people were killed when a medical transport plane crashed near Chinle Airport, the Navajo Police Department said. The small, dual-propeller aircraft was heading to pick up a patient from a nearby hospital when it crashed and caught on fire around 12:40 p.m. on Aug. 5, police said. 'This is a tragic loss to the families of those onboard and to the medical air and first responder community,' Navajo police said in a social media post. 'We extend our deepest condolences to their family and loved ones during this time.' The passengers were 'non-local," police said. The Albuquerque aircraft company CSI Aviation conducted next-of-kin notifications, according to police. The reason for the crash was unknown, as of Aug. 5. The National Traffic Safety Bureau and the Federal Aviation Administration were set to investigate the crash, police said. The Navajo Police Department Chinle District responded to the crash as did Navajo EMS and Navajo Nation Fire & Rescue Services, police said. Chinle Airport, located in Apache County, is owned by the Navajo Nation, according to the Navajo Nation Division of Transportation. Arizona has seen several municipal airport crashes in the past year, including in Scottsdale and Marana. Stephanie Murray covers national politics and the Trump administration for The Arizona Republic and Reach her via email at and on X, Bluesky, TikTok and Threads @stephanie_murr. This article originally appeared on Arizona Republic: AZ medical transport plane crash near Chinle Airport leaves 4 dead Solve the daily Crossword

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store